Compare Remala Abadi Tbk. (DATA) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Remala Abadi Tbk. vs Diagnos Laboratorium Utama Tbk. — how do they compare? Remala Abadi Tbk. trades at Rp1,920 (market cap 2.61T, 681.2K 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp230 (market cap 321.75B, 152.8K 24h volume). The key difference: Remala Abadi Tbk. is far larger — about 8.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Remala Abadi Tbk. is more actively traded (681.2K versus 152.8K). Which is the better fit depends on your goals.
| DATA | DGNS | |
|---|---|---|
Market Cap | 2.61T | 321.75B |
Volume | 681.2K | 152.8K |
Lot | 6.81K | 1.53K |
Turnover | 1.3B | 35.37M |
Average Price | 1,906.68 | 231.49 |
Value | 1.3B | 35.37M |
Indicative Equilibrium Price | 1,920 | 230 |
Indicative Equilibrium Volume | 72 | 1 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Remala Abadi Tbk.
PT. Remala Abadi Tbk (the Company) was established based on Deed No.5, dated March 15, 2004 made before Notary Fajra Rizqi Nasution, SH. The company started its commercial activities since 2004.
Read more on DATA →About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
